# US 12,605,393 B2 · Compositions for oral or nasal use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 12,605,393 B2
- Document ID: US12605393B2
- Status: Granted
- Kind: B2
- Application number: 17/922,623
- Filed: 2021-05-07
- Published: 2023-06-01
- Granted: 2026-04-21
- Earliest claimed: 2020-05-07
- Assignees: Liw Innovation AB
- Applicants: Liw Innovation AB
- Inventors: Lars Björkholm; Johan Björkholm
- Web page: https://patentgrep.com/patent/US12605393B2

## CPC

- A24B 13/00: Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14)
- A61K 31/658: {o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol}
- A24B 15/42: by organic and inorganic substances {(A24B15/281 takes precedence)}
- A61K 9/0043: {Nose}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/1694: {resulting in granules or microspheres of the matrix type containing more than 5% of excipient}
- A61K 31/465: Nicotine; Derivatives thereof
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/38: Cellulose; Derivatives thereof
- A61P 25/34: Tobacco-abuse
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1623: {Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules}
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A24B: MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The specification discloses compositions for use in the oral or nasal cavity comprising a biologically active agent, a matrix forming agent comprising alginate and suitable salts thereof, a filling agent and at least one antioxidant that is an effective complex binder. The compositions can further comprise additional excipients such as preservatives, taste or flavour enhancers, pH adjusters, plasticizers and sweeteners. The specification also discloses methods of producing the compositions.

## Claims

### Claim 1

A composition for use in the oral or nasal cavity, wherein the composition comprises an active agent selected from the group consisting of nicotine and a cannabinoid, a matrix forming agent comprising alginate and suitable salts thereof, a filling agent, a pH adjuster, and an antioxidant comprising an ammonium citrate wherein the antioxidant is an effective complex binder at a pH of 8 to 9, and the pH adjuster is to adjust the pH of the composition to a pH of 8 to 9, and is selected from the group consisting of monocarbonate, bicarbonate, sesquicarbonate, acetates, glycinates, gluconates, borates, glycerophosphates, citric acid, phosphates, sodium hydroxide, potassium hydroxide, and mixtures thereof.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the matrix forming agent comprises an at least one additional pharmaceutically acceptable gum.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the matrix forming agent comprises at least 50% (weight) of alginate and suitable salts thereof.

### Claim 4 (depends on 1)

The composition according to claim 1, comprising 5 to 95% (wt) of filling agent, comprising at least one plant fiber.

### Claim 5 (depends on 4)

The composition according to claim 4, wherein the filling agent further comprises a polyol.

### Claim 6 (depends on 1)

The composition according to claim 1, comprising at least one excipient selected from the group consisting of preservatives, taste or flavour enhancers, plasticizers and sweeteners.

### Claim 7 (depends on 1)

The composition according to claim 1, comprising less than 50% (wt) of the matrix forming agent.

### Claim 8 (depends on 1)

The composition according to claim 1, adapted to delivery to the nasal cavity, comprising less than 20% (wt) water.

### Claim 9 (depends on 8)

The composition according to claim 8, wherein the composition comprises powder particles having a particle size range of 0.01 to 2 mm.

### Claim 10 (depends on 8)

The composition according to claim 8, wherein the filling agent comprises a water soluble cellulose.

### Claim 11 (depends on 1)

The composition according to claim 1, adapted to contact with a mucous membrane of the oral cavity, comprising at least 30% (wt) of water and a filling agent comprising at least one member selected from the group consisting of microcrystalline cellulose and other plant fibers.

### Claim 12 (depends on 1)

The composition according to claim 1, comprising 40 to 60% (wt) water.

### Claim 13 (depends on 1)

The composition according to claim 1, adapted to contact with a mucous membrane of the oral cavity, comprising less than 40% (wt) of water and filling agent comprising at least one member selected from the group consisting of microcrystalline cellulose and other plant fibers.

### Claim 14 (depends on 1)

The composition according to claim 1, configured as a film suitable for transmucosal delivery of active agent having a thickness 0.01 to 7 mm, comprising at least 50% (wt) of the matrix forming agent and optionally a plasticizer.

### Claim 15 (depends on 14)

The composition according to claim 14, comprising 0.1 to 20% (wt) of filling agent and a plasticizer.

### Claim 16 (depends on 1)

The composition according to claim 1, wherein the alginate is sodium alginate.

### Claim 17 (depends on 1)

A method of manufacturing a composition according to claim 1, comprising:
(i) dry mixing filling agent and at least one of the matrix forming agent, an antioxidant and optionally at least one taste or flavour enhancer;
(ii) mixing the dry mixture with a first aqueous solution comprising a pH adjuster;
(iii) adding a second aqueous solution comprising at least one of a preservative, a taste or flavour enhancer and a sweetener;
(iv) adding a third aqueous solution comprising active agent and mixing all added components to a mixture with a suitable amount of water.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the filling agent is dry mixed with the matrix forming agent, the antioxidant and optionally at least one taste or flavour enhancer.

### Claim 19 (depends on 17)

The method according to claim 17, comprising dry mixing the filling agent, the antioxidant and optionally at least one taste or flavour enhancer, and wherein the third aqueous solution comprises the matrix forming agent and active agent.

### Claim 20 (depends on 17)

The method according to claim 17, configured to produce a powder composition for nasal use by one or more further processing steps of the resulting mixture, comprising drying to a powder of a particle size of less than 2 mm with less than 15% water (wt).

### Claim 21 (depends on 17)

The method according to claim 17, configured to produce a composition for use in the oral cavity by one or more further processing method of the resulting mixture with at least one of filling in pouches, tablet or lozenge forming, extrusion, punching, casting, moulding, injection moulding, kneading spinning, film forming and admixing with chewing gum base.
